1.
Pleura Peritoneum
; 7(1): 35-38, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35602921
RESUMEN
Objectives: Oxaliplatin immune-induced syndrome (OIIS) was recently recognized as an uncommon complication of oxaliplatin therapy. Methods: We report an exceptionally OIIS after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Results: Our patient developed a severe OIIS probably related to the intraperitoneal administration of oxaliplatin. Specific tests were performed and detected high-titer antibodies to oxaliplatin. Conclusions: The OIIS is a rare. Physicians had to be aware of that clinical situation because it could be reversible, even in case of peritoneal advanced disease, and ICU treatment is justified.
2.
Rev Prat
; 70(2): 183, 2020 02.
Artículo
en Francés
| MEDLINE
| ID: mdl-32877136